enoxacin has been researched along with Cancer of Mouth in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koide, N | 1 |
| Kasamatsu, A | 1 |
| Endo-Sakamoto, Y | 1 |
| Ishida, S | 1 |
| Shimizu, T | 1 |
| Kimura, Y | 1 |
| Miyamoto, I | 1 |
| Yoshimura, S | 1 |
| Shiiba, M | 1 |
| Tanzawa, H | 1 |
| Uzawa, K | 1 |
1 other study available for enoxacin and Cancer of Mouth
| Article | Year |
|---|---|
Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Prolife | 2017 |